MedPath

Potential Impact of the Use of the Application VentilO After Cardiac Surgery

Active, not recruiting
Conditions
Mechanical Ventilation Complication
Interventions
Other: VentilO application
Registration Number
NCT05886413
Lead Sponsor
Laval University
Brief Summary

Mechanical ventilation is a vital support associated with the treatment of patients with acute respiratory failure and in other indications such as surgery under general anesthesia, coma or shock. Optimization of settings during mechanical ventilation and implementation of protective ventilation help to avoid ventilation-induced injury, ensure adequate oxygenation and maintain adequate carbon dioxide concentration to avoid respiratory acidosis or alkalosis.

Similarly, there is also no clear recommendation, to our knowledge, for the initial setting of the respiratory rate. Therefore, initial settings are not always adequate and in the literature the frequency of respiratory acidosis is very high, reaching about half of the patients receiving mechanical ventilation.

VentilO, is an application that is available on smart phones. This educational application provides clinicians with initial settings and optimization of these settings based on gender, height, weight, body temperature and patient type. The algorithm used is based on published data regarding ventilatory requirements in different populations and the anatomical and instrumental dead space of patients.

The purpose of our study is to:

Assess whether ventilatory settings after intensive care unit admission after cardiac surgery are appropriate to compare the ventilatory adjustments made by clinicians with those proposed by the VentilO application.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Adults (> or = 18 years old)
  • Intubated patients admitted to the ICU immediately postoperative from cardiac surgery
  • Obtained a postoperative arterial gas within 1 hour of arrival in the ICU
Exclusion Criteria
  • Lack of patient anthropometric data (height and weight) available in the patient record

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Intubated patient admitted in intensive care unit at the IUCPQ-UL after cardiac surgeryVentilO application-
Primary Outcome Measures
NameTimeMethod
acid-base abnormalities on arterial blood gasesOn the first result available of arterial blood gases after intensive care unit admission; 1 hour maximum after intensive care admission

Evaluate the frequency of acid-base abnormalities, either acidosis or alkalosis, of respiratory or mixed origin on the first arterial gases after intubation.

Respiratory acidosis is defined as a pH \< 7.35 with a PaCO2 \> 45 mmHg, and respiratory alkalosis as a pH \> 7.45 with a PaCO2 \< 35 mmHg)

Secondary Outcome Measures
NameTimeMethod
hemodynamic instabilitiesBetween Hour0 to Hour1 after intensive care unit admission

Number of arterial hypotension requiring vascular filling \> 1000 ml and/or use of vasopressors or inotropes such as levophed or adrenaline at \> 0.05 mcg/kg/min)

Acute renal failureup to 90 days. ICU stay - ICU admission through ICU discharge or until death if occured

rate of acute renal failure during ICU length of stay. Renal failure will be defined according to the usual criteria, i.e., an increase of \>27 mmol/L creatinine in 48 hours or 1.5x over the preoperative baseline

Severity of unbalance of arterial blood gases resultOn the first result available of arterial blood gases after intensive care unit admission; 1 hour maximum after intensive care admission

For acid-base abnormalities, they will be evaluated according to their level of severity: the frequency of moderate (pH between 7.30 and 7.34) and severe (pH \< 7.30) acidoses, and the frequency of moderate (pH between 7.46 and 7.50) and severe (pH \> 7.50) alkaloses.

The frequency of moderate (PaCO2 between 46 and 50 mmHg) and severe (PaCO2 \> 50 mmHg) hypercapnia, and the frequency of moderate (PaCO2 between 31 and 35 mmHg) and severe (PaCO2 \< 31 mmHg) hypocapnia.

Mechanical Ventilation durationup to 90 days. ICU stay - ICU admission through ICU discharge or until death if occured

Time spent with invasive mechanical ventilation during ICU length of stay

Hospital length of stayup to 90 days. ICU stay - ICU admission through ICU discharge or until death if occured

Hospital length of stay - ICU admission through hospital discharge

Occurence of optimal arterial blood gases resultOn the first result available of arterial blood gases after intensive care unit admission; 1 hour maximum after intensive care admission

An optimal arterial blood gases as defined by a pH between 7.35 and 7.45 with a PaCO2 between 36 and 45 mmHg

ICU length of stayup to 90 days. ICU stay - ICU admission through ICU discharge or until death if occured

ICU length of stay - ICU admission through ICU discharge

ICU mortalityup to 90 days. ICU admission through until death if occured

Occurence of death during ICU stay

Trial Locations

Locations (1)

Institut Universitaire de Cardiologie et de Pneumologie de Québec

🇨🇦

Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath